At the time of writing, Health Catalyst Inc [HCAT] stock is trading at $7.77, down -3.36%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The HCAT shares have lost -0.13% over the last week, with a monthly amount drifted -1.65%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Health Catalyst Inc [NASDAQ: HCAT] stock has seen the most recent analyst activity on April 10, 2024, when KeyBanc Capital Markets downgraded its rating to a Sector Weight. Previously, Evercore ISI upgraded its rating to Outperform on January 03, 2024, and kept the price target unchanged to $11. On January 03, 2024, Barclays initiated with a Overweight rating and assigned a price target of $14 on the stock. JP Morgan upgraded its rating to a Overweight and decreased its price target to $11 on December 13, 2023. Piper Sandler upgraded its rating to a Overweight and reduced its price target to $11 on November 13, 2023. Cantor Fitzgerald started tracking with a Overweight rating for this stock on August 01, 2023, and assigned it a price target of $16. In a note dated May 10, 2023, Raymond James downgraded an Mkt Perform rating on this stock.
For the past year, the stock price of Health Catalyst Inc fluctuated between $5.42 and $11.41. Currently, Wall Street analysts expect the stock to reach $29.25 within the next 12 months. Health Catalyst Inc [NASDAQ: HCAT] shares were valued at $7.77 at the most recent close of the market. An investor can expect a potential return of 276.45% based on the average HCAT price forecast.
Analyzing the HCAT fundamentals
According to Health Catalyst Inc [NASDAQ:HCAT], the company’s sales were 299.48M for trailing twelve months, which represents an 3.67% jump. Gross Profit Margin for this corporation currently stands at 0.35% with Operating Profit Margin at -0.25%, Pretax Profit Margin comes in at -0.29%, and Net Profit Margin reading is -0.29%. To continue investigating profitability, this company’s Return on Assets is posted at -0.12, Equity is -0.24 and Total Capital is -0.2. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.7.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 7.66 points at the first support level, and at 7.55 for the second support level. However, for the 1st resistance point, the stock is sitting at 7.95, and for the 2nd resistance point, it is at 8.13.
Ratios To Look Out For
It is important to note that Health Catalyst Inc [NASDAQ:HCAT] has a current ratio of 1.18. As well, the Quick Ratio is 1.18, while the Cash Ratio is 0.63. Considering the valuation of this stock, the price to sales ratio is 1.57, the price to book ratio is 1.31.
Transactions by insiders
Recent insider trading involved Llewelyn Linda, Chief People Officer, that happened on Oct 15 ’24 when 1324.0 shares were sold. Officer, LINDA LLEWELYN completed a deal on Oct 15 ’24 to buy 1324.0 shares. Meanwhile, Chief Operating Officer LeSueur Daniel sold 5209.0 shares on Oct 03 ’24.
